Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT05441046 · UNKNOWN
Trial details
- NCT number
- NCT05441046
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2024-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.